S1PR1 and Alzheimer disease: EA treatment also mainly functions by decreasing S1PR1 expression in the cortex and hippocampus (a more pronounced effect observed on the right hippocampus), which provides evidence for EA's efficacy in improving cognitive and memory behavior in AD mice by acting on S1PR1 in the cortex and hippocampus (Tables 1 and 2).